Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
09/10/2008 | CN101259279A Biocompatibile monodisperse nano polymer carrier and its preparation and medicine-carrying method |
09/10/2008 | CN101259278A Optimum matching multiple water-soluble vitamin medicinal composition containing high-efficiency bacteriostat and preparation thereof |
09/10/2008 | CN101259277A Novel orthopaedics medicaments carrier system and preparation thereof |
09/10/2008 | CN101259179A Chinese medicine í«naodeshengí» soft capsule and preparation thereof |
09/10/2008 | CN101259170A Moistureproof and preparation technique for white peony extract |
09/10/2008 | CN101259162A Plaster containing lamioplomis rotata extract and preparation thereof |
09/10/2008 | CN101259161A Production technology of cream for treating toothache and odontitis |
09/10/2008 | CN101259150A Sustained-release pellet of ginkgo biloba extract and its preparation |
09/10/2008 | CN101259149A Tinctura for treating beriberi |
09/10/2008 | CN101259148A Microbial source liver-protecting natural nutrition health products and preparation |
09/10/2008 | CN101259145A Moistureproof and preparation technique for Chinese medicine extract |
09/10/2008 | CN101259143A Soluble effervescent preparations |
09/10/2008 | CN101259141A Compound alginic acid chewable tablet and preparation thereof |
09/10/2008 | CN101259140A Compound medicaments treating gastritis, gastric ulcer, and duodenal ulcer and preparation thereof |
09/10/2008 | CN101259138A Anti-inflammation and ease-pain composition topical application for animal kinematic scheme part |
09/10/2008 | CN101259125A Anethol trithione injection emulsion and preparation thereof |
09/10/2008 | CN101259120A Methods of inducing terminal differentiation |
09/10/2008 | CN101259117A Externally-applied plaster of bullatacin for resisting acquired immuno-deficiency syndrome virus |
09/10/2008 | CN101259115A Orally-administered insulin soft capsule for treating diabetes and preparation thereof |
09/10/2008 | CN101259114A Vaginal effervescence tablet composition containing solid lipid |
09/10/2008 | CN101259109A Fast disintegrating preparations and preparation thereof |
09/10/2008 | CN101259108A Double-unit tablet containing acid-labile medicaments |
09/10/2008 | CN101259106A Nano controlled release compositions comprising a cephalosporin |
09/10/2008 | CN101259105A Radix astragali sugar-free type granule and preparation thereof |
09/10/2008 | CN101259104A Functionalization mesoporous molecular sieve used in adsorption and sustained-release alkaline drug method |
09/10/2008 | CN101259100A Etoposide preparations and preparation thereof |
09/10/2008 | CN101259099A Nano granule preparations of catharanthus roseus alkaloids anti-tumor medicaments and preparation thereof |
09/10/2008 | CN101259098A Long-acting low molecule heparin intraocular sustained-release system |
09/10/2008 | CN101259097A Magnetic tumor double-target polymer nano micelle and preparation thereof |
09/10/2008 | CN101259096A Antiparasitic medicaments compound long-acting sustained-release injection and preparation thereof |
09/10/2008 | CN101259091A Oral-cleaning orally disintegrating tablet and preparing technique thereof |
09/10/2008 | CN101259082A Root canal anti-inflammation developing agent and preparation thereof |
09/10/2008 | CN100417658C Prepn process and medicinal composition of amorphous Adefovir dipivoxil |
09/10/2008 | CN100417418C Nucleic acid-containing complex |
09/10/2008 | CN100417417C Surface-modified hydrophobically modified drug-carried chitosan polymer micelle and method for preparing same |
09/10/2008 | CN100417416C Medicine composition containing neohouttuynin sodium and solutol HS15 |
09/10/2008 | CN100417414C Methods for treating cancer using an immunotoxin |
09/10/2008 | CN100417409C Chinese medicine external use lotion for treating woman reproduction system inflammation |
09/10/2008 | CN100417408C Chineses medicine prepn with several treating functions and its prepn proces and application |
09/10/2008 | CN100417378C Oridonin clathrate compound, and medicinal prepn. thereof |
09/09/2008 | US7424529 System using host bus adapter connection tables and server tables to generate connection topology of servers and controllers |
09/09/2008 | US7423129 Antibodies to human eotaxin |
09/09/2008 | US7423028 Injectable pharmaceutical compositions comprising sodium diclofenac and β-cyclodextrin |
09/09/2008 | US7423024 Recombinant human alpha-fetoprotein as an immunosuppressive agent |
09/09/2008 | US7423022 Nucleic acids for inhibiting hairless protein expression and methods of use thereof |
09/09/2008 | US7423014 Insulin conjugates for treating diabetes mellitus |
09/09/2008 | US7423010 Delivering into phagocytic cells; targeting specific organelles; inhibiting, attenuating, arresting, combating and overcoming microbial infection of phagocytic mammalian cells in vivo and in vitro |
09/09/2008 | US7422764 Matrix-forming composition containing pectin |
09/09/2008 | US7422756 Mixture of fatty acid and cholesterol |
09/09/2008 | US7422752 Mutant forms of EtxB and CtxB and their use as carriers |
09/09/2008 | US7422740 Capable of inhibiting the cell division cycle in a target cell; for therapy of proliferative cell disorders and intracellular pathogens |
09/09/2008 | US7422739 Anti-CD20 antibodies |
09/09/2008 | US7422738 Combined cancer treatment methods using antibodies to aminophospholipids |
09/09/2008 | US7422735 Use of crosslinked cationic polymers in skin cosmetic and dermatological preparations |
09/09/2008 | US7422733 Antiinflammatory agents; anticancer agents; antidiabetic agents |
09/09/2008 | CA2409069C Hydrogel composition for transdermal drug delivery |
09/09/2008 | CA2362769C Microcapsules for sustained release of drugs |
09/09/2008 | CA2346868C Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent |
09/09/2008 | CA2336712C Transdermal plaster containing at least one active ingredient which influences blood serum lipid levels |
09/09/2008 | CA2332389C Liposomal preparations for the application of antiseptic agents to the interior of the body |
09/09/2008 | CA2332174C Nutritional supplement based on blackcurrant seed oil |
09/09/2008 | CA2263445C Pharmaceutical aerosol composition |
09/09/2008 | CA2242631C Polymers with controlled physical state and bioerodibility |
09/09/2008 | CA2171369C The use of virulence factors of pathogens to improve liposomal delivery of antibiotics and/or vaccines |
09/04/2008 | WO2008106689A2 Breakthrough pain management |
09/04/2008 | WO2008106571A2 Sustained release parenteral formulations of buprenorphine |
09/04/2008 | WO2008106503A2 Discrete size and shape specific pharmaceutical organic nanoparticles |
09/04/2008 | WO2008106228A2 Methods and compositions for normalizing meibomian gland secretions |
09/04/2008 | WO2008106129A2 Polymeric micelles for combination drug delivery |
09/04/2008 | WO2008105739A1 Drug implant carrier for drug delivery |
09/04/2008 | WO2008105663A1 Implant containing destructurized starch |
09/04/2008 | WO2008105662A1 Biodegradable material based on opened starch |
09/04/2008 | WO2008105514A1 Multibranched polyoxyalkylene derivative |
09/04/2008 | WO2008105504A1 Transdermal immune preparation, method for production of the same, and transdermal immunization method using the same |
09/04/2008 | WO2008105475A1 Lipid composition having excellent shape retention property and product |
09/04/2008 | WO2008105473A1 Anti-malignant-tumor agent |
09/04/2008 | WO2008105445A1 Transdermal pharmaceutical composition |
09/04/2008 | WO2008105325A1 Citrulline-containing beverage |
09/04/2008 | WO2008105178A1 Agent for enhancing the resistance of liposome against biological component, and liposome modified with the agent |
09/04/2008 | WO2008105174A1 Liposome for induction of cell-mediated immunity |
09/04/2008 | WO2008105038A1 Adhesive patch for mycosis |
09/04/2008 | WO2008104723A1 Method for producing polylactones and polylactams |
09/04/2008 | WO2008038140A3 Foamable vehicle comprising polypropylene glycol alkyl ether and pharmaceutical compositions thereof |
09/04/2008 | WO2008000429A3 Polymers with antimicrobial activity containing quaternary ammonium groups |
09/04/2008 | WO2007098466A3 Segmented degradable polymers and conjugates made therefrom |
09/04/2008 | US20080215140 Stents coated with biomolecules and process for their production |
09/04/2008 | US20080214849 for transporting drugs or as gene transport vehicles, as solubilizers for drugs of low solubility in water, and themselves as active ingredients against diseases such as cancer or leishmaniosis; (Z)-6-octadecenyl-1-phospho-N,N,N-trimethylpropylammonium |
09/04/2008 | US20080214695 Biocompatible crosslinked polymers with visualization agents |
09/04/2008 | US20080214682 Methods of treating pneumonic plague |
09/04/2008 | US20080214680 Application of arsenic as a cancer prevention agent |
09/04/2008 | US20080214677 Chitosan-Silicon Dioxide Coprecipitate and Use as Excipient in Solid Dosage Forms |
09/04/2008 | US20080214648 Hiv Prodrugs Cleavable by Cd26 |
09/04/2008 | US20080214557 Method for preparation of pharmaceutical composition having improved disintegratability and pharmaceutical composition manufactured by same method |
09/04/2008 | US20080214513 Method of treating middle ear infections |
09/04/2008 | US20080214502 Formulating an insecticide such as D-CIS|transallethrin that is miscible with a liquid fuel, adding a selected amount of the insecticide to a liquid fuel, and combusting the fuel and insecticide in an internal combustion engine |
09/04/2008 | US20080214467 Exendins and Exendin Agonists Modified with Albumin |
09/04/2008 | US20080214448 Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist Peptide |
09/04/2008 | US20080213890 Antibody-avidin fusion proteins as cytotoxic drugs |
09/04/2008 | US20080213425 Compositions Having Body Fat Reducing Function and Food and Drink Containing the Same |
09/04/2008 | US20080213393 Solid dosage forms; using polyoxyethylene glycol binder; antacids; antidepressants; blood pressure medications; calcium channel blockers; calcium supplements; chemotherapy medications; cold medicines; antihistamines; maintaining or promoting the elimination of feces in the bowel |